Ciencias de la Salud
Campo de conocimiento
![Foto de Ciencias de la Salud](/img/noimage.png)
![Foto de Gustave Roussy Cancer Campus](/img/noimage_org.png)
Gustave Roussy Cancer Campus
Villejuif, FranciaPublicaciones en colaboración con investigadoras/es de Gustave Roussy Cancer Campus (24)
2024
2023
-
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Frontiers in Oncology, Vol. 13
-
Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
Cells, Vol. 12, Núm. 5
-
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666
2021
-
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 4, pp. 463-475
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Targeting camkk2 and soc channels as a novel therapeutic approach for sensitizing acute promyelocytic leukemia cells to all-trans retinoic acid
Cells, Vol. 10, Núm. 12
2020
-
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease
Aging, Vol. 12, Núm. 17, pp. 16690-16708
2019
-
Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients
Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481
2018
-
Acetylome in human fibroblasts from Parkinson’s disease patients
Frontiers in Cellular Neuroscience, Vol. 12
-
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178
2017
-
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 18, Núm. 12, pp. 1688-1700
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
Pompe disease and autophagy: Partners in crime, or cause and consequence?
Current Medicinal Chemistry, Vol. 23, Núm. 21, pp. 2275-2285
2014
-
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
British Journal of Surgery, Vol. 101, Núm. 13, pp. 1758-1765
2012
-
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Journal of Clinical Oncology, Vol. 30, Núm. 20, pp. 2449-2456
-
Implications of a positive sentinel node in oral squamous cell carcinoma
Head and Neck, Vol. 34, Núm. 11, pp. 1580-1585